WO2023031946 - EFFERVESCENT PHARMACEUTICAL COMPOSITION OF ASCORBIC ACID AND ZINC
National phase entry is expected:
Publication Number
WO/2023/031946
Publication Date
09.03.2023
International Application No.
PCT/IN2021/051143
International Filing Date
08.12.2021
Title **
[English]
EFFERVESCENT PHARMACEUTICAL COMPOSITION OF ASCORBIC ACID AND ZINC
[French]
COMPOSITION PHARMACEUTIQUE EFFERVESCENTE D'ACIDE ASCORBIQUE ET DE ZINC
Applicants **
KUSUM HEALTHCARE PVT. LTD.
Inventors
GUPTA, Sanjeev
GUPTA, Rajeev
CHANDRASHEKHAR, Tg
MUKHERJEE, Swati
GUPTA, Amit
VIJAY, Ankit
Priority Data
202111039571
01.09.2021
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP India
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1955 | |
| EPO | Filing, Examination, Granting | 11611 | |
| Japan | Filing, Examination, Granting | 2014 | |
| South Korea | Filing, Examination, Granting | 1788 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
23,308
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present invention relates to an effervescent solid oral pharmaceutical composition comprising high amount of ascorbic acid or its pharmaceutically acceptable salts and Zinc or its pharmaceutically acceptable salts and a method of preparing the same. The effervescent solid oral pharmaceutical composition prepared by the process of the invention is also stable when subjected to stress conditions at a temperature of 40°C. and relative humidity ("RH") of 75% for a period of at least six months.[French]
La présente invention concerne une composition pharmaceutique orale solide effervescente comprenant une quantité élevée d'acide ascorbique ou ses sels pharmaceutiquement acceptables et du zinc ou ses sels pharmaceutiquement acceptables et son procédé de préparation. La composition pharmaceutique orale solide effervescente préparée par le procédé de l'invention est également stable lorsqu'elle est soumise à des conditions de contrainte à une température de 40 °C et une humidité relative ("HR") de 75 % pendant une période d'au moins six mois.